NCT06948084
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
Not specified
Clinical trial condition
Multiple Myeloma
Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.
2,608 public trials
494 recruiting studies
Multiple Myeloma trial results
Not Yet Recruiting
Clinical Study of TQB2934 Injection in Relapsed/Refractory Multiple Myeloma
NCT07569757
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- The First Affiliated Hospital of Bengbu Medical University Bengbu, Anhui, China
- The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
- Beijing Chao-Yang Hospital,Capital Medical University Beijing, Beijing Municipality, China
- Beijing Jishuitan Hospital,Capital Medical University Beijing, Beijing Municipality, China
Not Yet Recruiting
Emapalumab Prophylaxis of Bispecific T-Cell Engagers (BiTEs) Associated CRS and ICANS
NCT07567014
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- NYU Langone Health Perlmutter Cancer Center - Sunset Park Brooklyn, New York, United States
- NYU Langone Health Perlmutter Cancer Center - Manhattan Manhattan, New York, United States
- NYU Langone Health - Long Island Mineola, New York, United States
Not Yet Recruiting
Infection Surveillance of R/R Multiple Myeloma Patients Treated With Elranatamab as Clinical Practice in Italy
NCT07564128
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
Not specified
Not Yet Recruiting
BCMA Bispecific Antibody Therapy for Post-BCMA CAR T-Cell Therapy Relapse (RECLAIM)
NCT07009899
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Froedtert & the Medical College of Wisconsin Milwaukee, Wisconsin, United States
Not Yet Recruiting
Cognitive Impairment in Patients Undergoing Cell- and Antibody-based Immunotherapies for Haematological Malignancies: The COGNITOX Study
NCT07558057
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
- Locations
-
- Aarhus University Hospital Aarhus, Denmark
NCT07542418
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
Not specified
Not Yet Recruiting
A Clinical Study to Evaluate the Safety and Preliminary Efficacy of QI-019B in Patients With Relapsed/Refractory Multiple Myeloma.
NCT07539233
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China
Not Yet Recruiting
BR101 in Patients With Relapsed/Refractory Multiple Myeloma
NCT07537049
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, China
Not Yet Recruiting
FT836 CAR T-cell Therapy in Combination With Daratumumab in Patients With Relapsed and/or Refractory Multiple Myeloma
NCT07221032
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Froedtert & the Medical College of Wisconsin Milwaukee, Wisconsin, United States